No Result

View All Result

No products in the cart.

Home StudyGraphics

#VisualAbstract Addition of daratumumab to standard of care improves minimal residual disease negativity in patients with newly diagnosed, transplant-ineligible multiple myeloma

byKathleen Lau

July 23, 2021

in StudyGraphics

RELATED REPORTS

New model enhances prediction of prostate cancer-specific mortality

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

Automated behavioral intervention for improving workplace diet did not prevent weight gain

RelatedReports

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Weekly Rewinds

New model enhances prediction of prostate cancer-specific mortality

January 12, 2026

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]

Cardiology

2 Minute Medicine: Pharma Roundup – New oral gonorrhea antibiotic Nuzolvence (zoliflodacin), late‑December cardiovascular and oncology drug approvals, first targeted complement inhibitor therapy for HSCT‑TMA (Yartemlea), and antibody‑drug conjugate (ADC) safety concerns with ifinatamab deruxtecan (I‑DXd) [January 2026]

January 12, 2026

Chronic Disease

High-flow nasal therapy with room air and fan therapy provide modest relief of dyspnea in advanced cancer patients who are not hypoxemic

January 12, 2026

Adjuvant celecoxib not associated with improved disease-free survival in patients with ERBB2-negative breast cancer

Abusive head trauma results in fewer productive life-years

Computed tomography findings may be useful in prognostication for mild traumatic brain injury

Home health management of patients undergoing deep brain stimulation for Parkinson’s disease is safe and feasible

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

No Result

View All Result

#VisualAbstract Addition of daratumumab to standard of care improves minimal residual disease negativity in patients with newly diagnosed, transplant-ineligible multiple myeloma

2 Minute Medicine Rewind

New model enhances prediction of prostate cancer-specific mortality

Automated behavioral intervention for improving workplace diet did not prevent weight gain

Adjuvant celecoxib not associated with improved disease-free survival in patients with ERBB2-negative breast cancer

RelatedReports

2 Minute Medicine Rewind

New model enhances prediction of prostate cancer-specific mortality

High-flow nasal therapy with room air and fan therapy provide modest relief of dyspnea in advanced cancer patients who are not hypoxemic

Adjuvant celecoxib not associated with improved disease-free survival in patients with ERBB2-negative breast cancer

Computed tomography findings may be useful in prognostication for mild traumatic brain injury

Home health management of patients undergoing deep brain stimulation for Parkinson’s disease is safe and feasible

Recent Reports